Close the acquisition of MyoKardia, Inc
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 13 Nov 2020
- Due
- 31 Dec 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“proposed acquisition (“Acquisition”) of MyoKardia, Inc. (“MyoKardia”), which is expected to close in the fourth quarter of 2020.”
What we found
Evidence strength A What the grades mean
The company's SEC filings confirm that the acquisition of MyoKardia was completed in 2020, as evidenced by financial charges and operational references related to the acquisition recognized within that year.
-
A Bristol Myers Squibb Co. 10-K filed 2021-02-10
“In addition, an $11.4 billion IPRD charge was recognized in 2020 for the MyoKardia acquisition.” ✓ confirmed on the page
-
A Bristol Myers Squibb Co. 10-Q filed 2021-04-29
“In the cardiovascular space, with the acquisition of MyoKardia in 2020, we bolstered our leading cardiovascular franchise” ✓ confirmed on the page
Market reaction: the shares moved -0.2% against the S&P 500 over the three sessions around the disclosure (9 Feb 2021 to 12 Feb 2021). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of MyoKardia, Inc.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Bristol Myers Squibb Co.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-BMY-003856 · Corrections policy